We are live on ! Find out more
CGNT

Cogentix Medical, Inc.
CGNT

Delisted

CGNT was delisted on the 20th of April, 2018.

Back to rankings

37 hedge funds and large institutions have $20.6M invested in Cogentix Medical, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

53% more capital invested

Capital invested by funds: $13.4M → $20.6M (+$7.13M)

9% more funds holding

Funds holding: 34 → 37 (+3)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$488K
2
MHP
Manatuck Hill Partners
Connecticut
+$329K
3
WPC
White Pine Capital
Minnesota
+$161K
4
Renaissance Technologies
Renaissance Technologies
New York
+$153K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$131K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$198K
2
PCM
Perkins Capital Management
Minnesota
-$185K
3
Millennium Management
Millennium Management
New York
-$70.8K
4
DCM
DAFNA Capital Management
California
-$65.7K
5
Goldman Sachs
Goldman Sachs
New York
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Searle & Co
Connecticut
$26K – – –
Macquarie Group
27
Macquarie Group
Australia
$20K +$17.2K +7,840 New
JP Morgan Chase
28
JP Morgan Chase
New York
$13K – – –
TDC
29
Thompson Davis & Co
Virginia
$13K +$11K +5,000 New
FWM
30
Focused Wealth Management
New York
$9K – – –
US Bancorp
31
US Bancorp
Minnesota
$7K – – –
UBS Group
32
UBS Group
Switzerland
$6K -$9.11K -4,156 -63%
Morgan Stanley
33
Morgan Stanley
New York
$5K -$19.2K -8,778 -81%
AG
34
Advisor Group
Arizona
$4K -$1.1K -500 -25%
Bank of America
35
Bank of America
North Carolina
$2K +$131 +60 +8%
WPC
36
White Pine Capital
Minnesota
$188 +$161K +73,400 New
Goldman Sachs
37
Goldman Sachs
New York
– -$33K -18,842 Closed
TRCT
38
Tower Research Capital (TRC)
New York
– -$30K -17,438 Closed
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
– -$22K -12,415 Closed
Creative Planning
40
Creative Planning
Kansas
– -$6K -3,633 Closed
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -816 Closed
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
– +$7 +3 New
1
2

CGNT Hedge Fund Activity: Q3 2017 in Review

37 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q3 2017, worth a combined $20.6M — up 53% from $13.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CGNT positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $488K. The largest seller was Broadfin Capital, cutting an estimated $198K.

  • 37 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q3 2017, up from 34 in Q2 2017.
  • Funds reported $20.6M of Cogentix Medical, Inc. stock for Q3 2017, up 53% quarter-over-quarter.
  • 9 funds opened new Cogentix Medical, Inc. positions in Q3 2017 and 5 closed out, a net change of +4 holders.
  • The largest Cogentix Medical, Inc. buyer in Q3 2017 was Vanguard Group, an estimated $488K added.
  • The largest Cogentix Medical, Inc. seller in Q3 2017 was Broadfin Capital, an estimated $198K sold.

Based on aggregated 13F filings for Q3 2017.